Back to Search
Start Over
Intra-arterial tirofiban in a male nonagenarian with acute ischemic stroke: A case report
- Source :
- Open Life Sciences, Vol 14, Iss 1, Pp 515-518 (2019)
- Publication Year :
- 2019
- Publisher :
- De Gruyter, 2019.
-
Abstract
- Nonagenarians with acute ischemic stroke tend to have a higher mortality and morbidity than younger patients. Tirofiban is a glycoprotein IIb/IIIa antagonist that has a therapeutic potential for ischemic stroke. Here, we provide a case report of a 93-year-old male patient with acute ischemic stroke. He presented with right-sided hemiparesis for 2 hours (National Institute of Health Stroke Scale, NIHSS = 23). Immediate treatment with endovascular tirofiban infusion achieved an improvement of intracranial blood flow and a progressively decreased NIHSS one day after admission (NIHSS = 16) and then seven days after admission (NIHSS = 7). After a follow-up of 90 days, the modified ranking score was 2. This case report suggests that endovascular application with tirofiban may be a favorable option for treating nonagenarians presenting with acute ischemic stroke and warrants further study.
Details
- Language :
- English
- ISSN :
- 23915412
- Volume :
- 14
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Open Life Sciences
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.743bf31b92242199d89f599b6dc8994
- Document Type :
- article
- Full Text :
- https://doi.org/10.1515/biol-2019-0057